CRISPR and Cas Gene Market to Grow at CAGR of 17.31% through 2033 - Rising Prevalence of Genetic Disorders & Diseases to Bolster Growth [Yahoo! Finance]
CRISPR Therapeutics AG - Common Shares (CRSP)
Last crispr therapeutics ag - common shares earnings: 8/7 05:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
nasdaq.com/symbol/crsp/real-time
Company Research
Source: Yahoo! Finance
Recent progress in biotechnological research has opened up many applications for CRISPR and Cas gene systems, directly or indirectly contributing to human health. In addition, the straightforward design, cost-effectiveness, high efficiency, reproducibility, and rapid turnaround time of CRISPR-Cas systems have led to their widespread adoption in genome editing technology within molecular biology laboratories worldwide. This aspect is anticipated to drive market growth significantly over the forecast years. Newark, May 07, 2024 (GLOBE NEWSWIRE) -- The Brainy Insights estimates that the USD 3.16 billion in 2023 global CRISPR and Cas Gene market will reach USD 15.60 billion by 2033. Cell and gene therapy is rapidly evolving, with CRISPR-Cas gene editing playing a central role in therapeutic development. Opportunities exist for developing CRISPR-modified cell therapies, including CAR-T cells, stem cell therapies, and engineered immune cells, for personalized and targeted treatments of ca
Show less
Read more
Impact Snapshot
Event Time:
CRSP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CRSP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CRSP alerts
High impacting CRISPR Therapeutics AG - Common Shares news events
Weekly update
A roundup of the hottest topics
CRSP
News
- CRISPR Therapeutics AG (NASDAQ: CRSP) had its price target lowered by analysts at Citigroup Inc. from $89.00 to $84.00. They now have a "buy" rating on the stock.MarketBeat
- CRISPR Therapeutics Strengthens Executive Leadership Team with Key Appointments Thu, May 23, 2024, 2:00 PM GMT+2 5 min read 0 In this article: Advertisement Up next Should You Buy QuantumScape Stock While It's Below $10? Thu, May 23, 2024, 10:50 AM GMT+2Acquire Media Monitor
- CRISPR Therapeutics Strengthens Executive Leadership Team with Key AppointmentsGlobeNewswire
- Is CRISPR Therapeutics a Millionaire Maker? [Yahoo! Finance]Yahoo! Finance
- Bull Market Buys: 2 Growth Stocks to Own for the Long Run [Yahoo! Finance]Yahoo! Finance
CRSP
Earnings
- 5/9/24 - Beat
CRSP
Sec Filings
- 5/24/24 - Form 4
- 5/23/24 - Form 3
- 5/23/24 - Form 8-K
- CRSP's page on the SEC website